Active — Not RecruitingNot Applicable

Family History and Cancer Risk Study

United States1,847 participantsStarted 2022-01-01

Plain-language summary

Investigators from Vanderbilt University Medical Center (VUMC), Duke University, and Meharry Medical College (MMC) are collaborating on a family health history study to deploy a family health history (FHH) platform, MeTree. Recruited participants will complete surveys, the MeTree questionnaire, and MeTree will determine the participant's cancer risk based on current guidelines. The study team will offer genetic counseling to high-risk participants. Investigators will track participant outcomes and behaviors from the use of MeTree to determine the efficiency of the use of MeTree compared to completion of pedigrees in clinic.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Receiving care at sites included in study * Able to read and communicate in English * Willing to use the Internet * Currently enrolled in the patient portal, or willing to enroll (VUMC-specific) Exclusion Criteria: * Non-study site patient * Diagnosed with a terminal illness * Unable to speak/read English * Unable/unwilling to use the Internet * Previous genetic testing and/or counseling from the VUMC Hereditary Cancer Clinic

What they're measuring

MeTree Completion (REACH)

Timeframe: From enrollment to study completion (up to 3 years)

Trial details

NCT IDNCT05079334

SponsorVanderbilt University Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-08-31

Results submitted2025-11-13

View on ClinicalTrials.gov More Neoplastic Syndromes, Hereditary trials